Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

11084	Companies
243306	Keywords
171464	Articles
131025	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 05/21/2025 at 14:00, 1 year 4 months ago

Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Jaguar Health, Inc. announces purchase of 246,306 shares of common stock at $6.09 per share in a registered direct offering. H.C. Wainwright & Co. serves as exclusive placement agent

Shares Stock Purchase Jaguar Health H.C. Wainwright & Co. Direct Offering
BRIEF

published on 05/20/2025 at 15:20, 1 year 4 months ago

Jaguar Health lance un essai de phase 2 pour le Crofelemer chez les patients pédiatriques atteints de MVID

Crofelemer Jaguar Health Essai De Phase 2 MVID Traitement Pédiatrique
BRIEF

published on 05/20/2025 at 15:20, 1 year 4 months ago

Jaguar Health Begins Phase 2 Trial for Crofelemer in Pediatric MVID Patients

Crofelemer Jaguar Health Phase 2 Trial MVID Pediatric Treatment
PRESS RELEASE

published on 05/20/2025 at 15:15, 1 year 4 months ago

First Patient Randomized in Jaguar Health’s Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID)
Jaguar Health's crofelemer shows promise in reducing total parenteral support in pediatric MVID patient. Ongoing trials and future expectations discussed

Crofelemer Clinical Trials Jaguar Health Pediatric MVID Total Parenteral Support
BRIEF

published on 05/19/2025 at 16:42, 1 year 4 months ago

Jaguar Health Inc. reçoit une note d'achat de First Berlin Equity Research

Crofelemer Jaguar Health Approbation De La FDA Acheter Une Note Potentiel De Croissance
BRIEF

published on 05/19/2025 at 16:42, 1 year 4 months ago

Jaguar Health Inc Receives Buy Rating from First Berlin Equity Research

Crofelemer FDA Approval BUY Rating Jaguar Health Growth Potential
PRESS RELEASE

published on 05/19/2025 at 16:37, 1 year 4 months ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Jaguar Health Inc, recommending a Buy with USD 60.00 price target. Jaguar focuses on plant-based medicines for GI health challenges, with crofelemer as flagship product

Jaguar Health Inc First Berlin Equity Research BUY Rating Plant-based Medicines GI Health Challenges
BRIEF

published on 05/15/2025 at 20:35, 1 year 4 months ago

Jaguar Health annonce une baisse de son chiffre d'affaires au premier trimestre 2025

Baisse Des Revenus Produits Sur Ordonnance Réunion De La FDA Résultats Financiers Du Premier Trimestre 2025 Croissance De Mytesi
BRIEF

published on 05/15/2025 at 20:35, 1 year 4 months ago

Jaguar Health Reports Decreased Revenue in Q1 2025

Revenue Decline Prescription Products FDA Meeting Q1 2025 Financials Mytesi Growth
PRESS RELEASE

published on 05/15/2025 at 20:30, 1 year 4 months ago

Jaguar Health Reports First Quarter 2025 Financials
Jaguar Health, Inc. reports Q1 2025 financial results with revenue decrease, Mytesi prescription volume changes, and promising POC results for rare diseases. FDA meeting on Phase 3 trial for breast cancer subgroup

Financial Results Jaguar Health Q1 2025 Mytesi Prescription POC Results

Accesswire

Published on 09/26/2026 at 01:00, 2 days 4 hours ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 2 days 4 hours ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 7 hours ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 12 hours ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 14 hours ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

EQS Group

Published on 09/27/2026 at 17:05, 12 hours 54 minutes ago

Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 14 hours ago

QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 14 hours ago

QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 14 hours ago

Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 22 hours ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe

Les Echos

Published on 09/26/2026 at 07:00, 1 day 22 hours ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 2 days 11 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 2 days 11 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 2 days 12 hours ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 12 hours ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE